Advocacy Conditions Pharmaceutical Policy 
Veriheal
FEBRUARY 21, 2023
Despite notable advances in MMJ research over the last decade, scientists have found that some states’ restrictions on qualifying conditions prevent millions of patients from getting the treatments they need—robbing them of potential relief offered by cannabinoid therapies. Many patients take MMJ for more reasons than one.
Cannabis Law Report
APRIL 21, 2022
We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. We are a new kind of pharmaceutical company that prioritizes public benefit over profit and is committed to sustainability, accountability, and transparency. Minimum Requirements.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 21, 2022
Kabir Nath brings decades of experience in the health care industry to his new role, most recently serving as Senior Managing Director of global pharmaceuticals at Otsuka Pharmaceutical Co.,
NORML
NOVEMBER 8, 2019
Polling from the American Legion shows that nearly 1 in 4 veterans consume marijuana to alleviate symptoms of a medical or physical condition. Prohibiting VA doctors from recommending cannabis to qualifying patients, while continuing to rely on pharmaceuticals drugs like opioids as a treatment, is both a dangerous and illogical policy.
Cannabis Law Report
OCTOBER 14, 2021
formerly the Canadian Association of Retired Persons), Canada’s largest advocacy association for Canadians As We Age. Understanding the utility of medical cannabis is increasingly important to older Canadians for the treatment of conditions including chronic pain, anxiety and lack of sleep. ’s advocacy. Most C.A.R.P.
CannaTech
AUGUST 9, 2018
We are delighted to introduce you to some new friends set to make a big impact on the medical cannabis advocacy scene… the creators of a new documentary called Separating the Strains ; a deeply personal narrative that charts the reality of living with epilepsy, with and without cannabis medication as a treatment option.
NORML
JANUARY 11, 2019
The measure would allow Virginia’s licensed practitioners to recommend and pharmaceutical processors to dispense full therapeutic-strength medical cannabis oil. Senate Bill 19-013 would permit physicians to recommend cannabis therapy for any condition for which an opiate would otherwise be prescribed. NY resident? New Mexico.
Expert insights. Personalized for you.
98 
Let's personalize your content